Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions

AIM: To quantify drug-drug-interactions (DDIs) encountered in patients prescribed hepatitis C virus (HCV) treatment, the interventions made, and the time spent in this process. METHODS: As standard of care, a clinical pharmacist screened for DDIs in patients prescribed direct acting antiviral (DAA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Langness, Jacob A, Nguyen, Matthew, Wieland, Amanda, Everson, Gregory T, Kiser, Jennifer J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340814/
https://www.ncbi.nlm.nih.gov/pubmed/28321163
http://dx.doi.org/10.3748/wjg.v23.i9.1618

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340814/
https://www.ncbi.nlm.nih.gov/pubmed/28321163
http://dx.doi.org/10.3748/wjg.v23.i9.1618

Ejemplares similares